According to a recent report from the President’s Council of Advisors on Science & Technology, the United States should set a goal of doubling the output of innovative new medicines that meet critical public health needs over the next 10 to 15 years, while continuing to increase drug safety.
The council recommends a number of actions involving industry, academia, and the Federal Government. See the full report here – http://www.whitehouse.gov/sites/default/files/microsites/ostp/pcast-fda-final.pdf
